Recent Analyst Stock Rating Upgrade News
Leerink Partners Upgrades Myriad Genetics to Outperform, Raises Price Target to $35
Stephens & Co. Upgrades Redfin to Overweight, Raises Price Target to $9
Alliance Global Partners Upgrades Aterian to Buy
TD Cowen Upgrades Real Matters to Buy, Announces C$7 Price Target
Wedbush Upgrades ExlService Holdings to Outperform, Raises Price Target to $40
Wells Fargo Upgrades Hexcel to Overweight, Raises Price Target to $95
B. Riley Securities Upgrades Crexendo to Buy, Lowers Price Target to $5.75
JP Morgan Upgrades Intl Flavors & Fragrances to Overweight, Raises Price Target to $100
Jefferies Upgrades Envestnet to Hold, Raises Price Target to $59
Canaccord Genuity Upgrades Confluent to Buy, Raises Price Target to $35
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.